Treatment of multidrug-resistant Pseudomonas aeruginosa bacteremia using ceftolozane-tazobactam-based or colistin-based antibiotic regimens: A multicenter retrospective study

Treatment of multidrug-resistant Pseudomonas aeruginosa bacteremia using ceftolozane-tazobactam-based or colistin-based antibiotic regimens: A multicenter retrospective study

Background: Ceftolozane-tazobactam is an emerging ‎treatment for severe infections caused by multidrug-resistant (MDR) Pseudomonas ‎aeruginosa. However, limited ‎data support its use in bacteremia treatment. This study aimed to assess the effectiveness of the treatment of MDR P. aeruginosa bacteremi...

Full description

Bibliographic Details
Main Authors: Hakeam A. Hakeam, Ghadi Askar, Khalid Al Sulaiman, Reem Mansour, Maha M. Al Qahtani, Dana Abbara, Nada Aldhayyan, Nariman Dyab, Liyan Afaneh, Muna Islami, Zainab Al Duhailib
Format: Article
Language:English
Published: Elsevier 2022-10-01
Series:Journal of Infection and Public Health
Subjects:
MDR P. aeruginosa
Ceftolozane-tazobactam
Colistin
Bacteremia
Bloodstream ‎infection
Online Access:http://www.sciencedirect.com/science/article/pii/S1876034122002350

Similar Items

Similar Items